Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
MedicQuant ApS logo — Rapid Answers For Better Treatment

MedicQuant ApS

Rapid Answers For Better Treatment

Founded 2019 Denmark Denmark 12 employees Seed Total: $12.00M Biotechnology, Health Care +1

General Information

Company Name MedicQuant ApS
Founded Year 2019
Location Denmark Denmark +1
Employees 12
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Seed
Social

Get notified when MedicQuant ApS moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About MedicQuant ApS

MedicQuant ApS is a Denmark-based startup with a vision to enable rapid and local tests for anticoagulants at the point-of-care to benefit patients. The company aims to address the lack of readily available solutions to measure blood levels of anticoagulants, known as Direct Oral Anticoagulants (DOACs), at the point-of-care. MedicQuant has developed a novel technology utilizing a chip and instrument that can detect anticoagulants directly from whole blood within 10 minutes. The elegant simplicity of their solution holds the potential to be readily available at the point of care. Founded in 2019, the company operates in the Biotechnology and Health Care sectors. Their recent milestone includes a kr12.00M Seed Round investment on 23 April 2023, with contributions from investors including Volvere plc, Export and Investment Fund, and Den Midtjyske Inværksätterfond. MedicQuant's innovative approach to improving patient care and their ability to attract significant investments showcase strong potential for growth and impact in the healthcare industry.

Taxonomy: diagnostic kits, point-of-care testing, anticoagulants testing, DOACs detection, biomedical devices

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 3
Investor Investor
•••• •••• 		23 Apr 2023
Convertible Note •••••• 1
Investor
08 Nov 2019

MedicQuant ApS Alternatives & Competitors

MedicQuant ApS vs
Ativa
Ativa United States

Decoding Blood, Changing Care.

Series Unknown
20 employees
Biotechnology, Health Care
MedicQuant ApS vs
Genalyte, Inc.
Genalyte, Inc. United States

Transform the doctor-patient relationship by bringing the doctor, the patient, and the lab together...

Unknown
91 employees
Biotechnology, Health Care
MedicQuant ApS vs
BRAINBox Solutions, Inc.
BRAINBox Solutions, Inc. United States

Providing the Comprehensive TBI Solution

Series B
18 employees
Biotechnology, Health Care

FAQ About MedicQuant ApS

Rapid Answers For Better Treatment
MedicQuant ApS was founded in 2019.
MedicQuant ApS is headquartered in Denmark.
MedicQuant ApS operates in the following industries: Biotechnology, Health Care, Medical Devices.
MedicQuant ApS has approximately 12 employees.
MedicQuant ApS has completed 2 funding rounds, raising a total of $12.00M. The latest funding stage is Seed.
Top alternatives and competitors to MedicQuant ApS include Ativa, Genalyte, Inc., BRAINBox Solutions, Inc., Haemokinesis, RedDrop Dx. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MedicQuant ApS and Ativa are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors MedicQuant ApS and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes